Impact of perioperative high-protein nutritional support on the quality of life of patients with primary lung cancer: a Russian prospective multicenter comparative study (NUTRILUNC study)

Abstract

BACKGROUND: Individuals over the age of 70 comprise over half of operable patients with stage 0–IIIA lung cancer. In the early postoperative period of this cohort, pain, fatigue, insomnia, and/or mood disturbances are the four most common symptoms, which can significantly diminish quality of life and functional status. Perioperative nutritional support in such patients, which enhances exercise tolerance, can have a positive impact on their quality of life and socialization.

AIM: To assess the effect of perioperative nutritional support using high-protein oral nutrition supplements on the general health and quality of life of non-small cell lung cancer patients during the postoperative period.

MATERIALS AND METHODS: Patients with primary non-small cell lung cancer (n=112, 69 males), aged 57.2±8.2, who were awaiting lung surgery and at risk of malnutrition (Nutritional Risk Screening Assessment 2002 score ≥3) were randomly assigned into two groups. Oral nutritional support (Nutridrink Compact Protein, Nutricia LLC) was administered to the study group (n=55) at a rate of 250 ml/d (36 g of protein, 612 kcal) for 14 days prior to and 14 days following the surgery, in addition to the standard diet. Control group patients (n=57) were provided a standard diet. The quality of life was assessed using the Quality of Life Questionnaire Core-30. Results are presented as mean ± standard deviation. Differences were considered significant at p ≤0.05.

RESULTS: Throughout the entire observation period, the study group exhibited superior growth indicators in terms of general health status, physical, and role functioning than the control group (p <0.05). The study group patients exhibited a propensity toward improved emotional functioning, and by the end of the study, weakness and insomnia were less pronounced (p <0.05). Other indicators did not exhibit any significant variations.

CONCLUSION: Нigh-protein perioperative oral nutrition supplements exert a positive impact on the quality of life of non-small cell lung cancer patients.

Keywords

lung cancer / perioperative nutritional support / quality of life

References

[1] Laktionov KK, Artamonova EV, Borisova TN, et al. Malignant neoplasm of the bronchi and lung: Russian clinical guidelines. Journal of Modern Oncology. 2021;23(3):369–402. doi: 10.26442/18151434.2021.3.201048

[2] Лактионов К.К., Артамонова Е.В., Борисова Т.Н., и др. Злокачественное новообразование бронхов и легкого. Клинические рекомендации // Современная онкология. 2021. Т. 23, № 3. С. 369–402. doi: 10.26442/18151434.2021.3.201048

[3] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492

[4] Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA Cancer J Clin. 2018. Vol. 68, N 6. P. 394–424. doi: 10.3322/caac.21492

[5] Janssen-Heijnen ML, Smulders S, Lemmens VE, et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax. 2004;59(7):602–607. doi: 10.1136/thx.2003.018044

[6] Janssen-Heijnen M.L., Smulders S., Lemmens V.E., et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer // Thorax. 2004. Vol. 59, N 7. P. 602–607. doi: 10.1136/thx.2003.018044

[7] Cheng X. Effects of lung rehabilitation therapy in improving respiratory motor ability and alleviating dyspnea in patients with lung cancer after lobectomy: a clinical study. Altern Ther Health Med. 2022;28(3):18–23.

[8] Cheng X. Effects of lung rehabilitation therapy in improving respiratory motor ability and alleviating dyspnea in patients with lung cancer after lobectomy: a clinical study // Altern Ther Health Med. 2022. Vol. 28, N 3. P. 18–23.

[9] Sommer MS, Staerkind MEB, Christensen J, et al. Effect of postsurgical rehabilitation programmes in patients operated for lung cancer: a systematic review and meta-analysis. J Rehabil Med. 2018;50(3):236–245. doi: 10.2340/16501977-2292

[10] Sommer M.S., Staerkind M.E.B., Christensen J., et al. Effect of postsurgical rehabilitation programmes in patients operated for lung cancer: a systematic review and meta-analysis // J Rehabil Med. 2018. Vol. 50, N 3. P. 236–245. doi: 10.2340/16501977-2292

[11] Chen HL, Liu K, You QS. Self-efficacy, cancer-related fatigue, and quality of life in patients with resected lung cancer. Eur J Cancer Care. 2018;27(6):e12934. doi: 10.1111/ecc.12934

[12] Chen H.L., Liu K., You Q.S. Self-efficacy, cancer-related fatigue, and quality of life in patients with resected lung cancer // Eur J Cancer Care. 2018. Vol. 27, N 6. P. e12934. doi: 10.1111/ecc.12934

[13] Obukhova OA, Kurmukov IA, Egofarov NM, et al. Impact of perioperative high-protein nutritional support on postoperative outcomes in the treatment of primary lung cancer: Russian prospective multicenter comparative study (NUTRILUNC-study). Clinical nutrition and metabolism. 2023;4(3):150–164. doi: 10.17816/clinutr625481

[14] Обухова О.А., Курмуков И.А., Егофаров Н.М., и др. Влияние периоперационной высокобелковой нутритивной поддержки на послеоперационные результаты лечения больных первичным раком лёгкого: российское проспективное многоцентровое сравнительное исследование (исследование NUTRILUNC) // Клиническое питание и метаболизм. 2023. Т. 4, № 3. С. 150–164. doi: 10.17816/clinutr625481

[15] Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi: 10.1093/jnci/85.5.365

[16] Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology // J Natl Cancer Inst. 1993. Vol. 85, N 5. P. 365–376. doi: 10.1093/jnci/85.5.365

[17] Shin JA, Kosiba JD, Traeger L, et al. Dyspnea and panic among patients with newly diagnosed non-small cell lung cancer. J Pain Symptom Manage. 2014;48:465–470. doi: 10.1016/j.jpainsymman.2013.10.021

[18] Shin J.A., Kosiba J.D., Traeger L., et al. Dyspnea and panic among patients with newly diagnosed non-small cell lung cancer // J Pain Symptom Manage. 2014. Vol. 48. P. 465–470. doi: 10.1016/j.jpainsymman.2013.10.021

[19] Park S, Kang CH, Hwang Y, et al. Risk factors for postoperative anxiety and depression after surgical treatment for lung cancerdagger. Eur J Cardiothorac Surg. 2016;49:16–21. doi: 10.1093/ejcts/ezv336

[20] Park S., Kang C.H., Hwang Y., et al. Risk factors for postoperative anxiety and depression after surgical treatment for lung cancerdagger // Eur J Cardiothorac Surg. 2016. Vol. 49. P. 16–21. doi: 10.1093/ejcts/ezv336

[21] Ivanova AS, Obukhova OA, Kurmukov IA, Volf LY. Review of ESPEN-2021 Practice Guidelines for Cancer Patients: Part 1. Clinical nutrition and metabolism. 2022;3(3):140–152. doi: 10.17816/clinutr111900

[22] Иванова А.С., Обухова О.A., Курмуков И.А., Вольф Л.Я. Обзор практических рекомендаций ESPEN-2021 для онкологических больных. Часть 1 // Клиническое питание и метаболизм. 2022. Т. 3, № 3. С. 140–152. doi: 10.17816/clinutr111900

[23] Ivanova AS, Obukhova OA, Kurmukov IA, Volf LY. Review of ESPEN-2021 Practice Guidelines for Patients with Cancer. Part 2: Interventions Relevant to Specific Patient Categories. Clinical nutrition and metabolism. 2022;3(4):193–206. doi: 10.17816/clinutr119059

[24] Иванова А.С., Обухова О.A., Курмуков И.А., Вольф Л.Я. Обзор практических рекомендаций ESPEN-2021 для онкологических больных. Часть 2: частные вопросы нутритивной поддержки // Клиническое питание и метаболизм. 2022. Т. 3, № 4. С. 193–206. doi: 10.17816/clinutr119059

[25] Kasprzyk A, Bilmin K, Chmielewska-Ignatowicz T, et al. The role of nutritional support in malnourished patients with lung cancer. In Vivo. 2021;35(1):53–60. doi: 10.21873/invivo.12231

[26] Kasprzyk A., Bilmin K., Chmielewska-Ignatowicz T., et al. The role of nutritional support in malnourished patients with lung cancer // In Vivo. 2021. Vol. 35, N 1. P. 53–60. doi: 10.21873/invivo.12231

[27] Krzakowski M, Jassem J, Antczak A, et al. Cancer of the lung, pleura and mediastinum. Oncol Clin Pract. 2019;15:20–50. doi: 10.5603/OCP.2018.0056

[28] Krzakowski M., Jassem J., Antczak A., et al. Cancer of the lung, pleura and mediastinum // Oncol Clin Pract. 2019. Vol. 15. P. 20–50. doi: 10.5603/OCP.2018.0056

[29] Ramos R, Nadal E, Peiró I, et al. Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancer. Eur J Surg Oncol. 2018;44(9):1419–1424. doi: 10.1016/j.ejso.2018.03.026

[30] Ramos R., Nadal E., Peiró I., et al. Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancer // Eur J Surg Oncol. 2018. Vol. 44, N 9. P. 1419–1424. doi: 10.1016/j.ejso.2018.03.026

[31] Landgrebe M, Tobberup R, Carus A, Rasmussen HH. GLIM diagnosed malnutrition predicts clinical outcomes and quality of life in patients with non-small cell lung cancer. Clin Nutr. 2023;42(2): 190–198. doi: 10.1016/j.clnu.2022.12.011

[32] Landgrebe M., Tobberup R., Carus A., Rasmussen H.H. GLIM diagnosed malnutrition predicts clinical outcomes and quality of life in patients with non-small cell lung cancer // Clin Nutr. 2023. Vol. 42, N 2. P. 190–198. doi: 10.1016/j.clnu.2022.12.011

[33] Polański J, Jankowska-Polańska B, Uchmanowicz I, et al. Malnutrition and Quality of Life in Patients with Non-Small-Cell Lung Cancer. Adv Exp Med Biol. 2017;1021:15–26. doi: 10.1007/5584_2017_23

[34] Polański J., Jankowska-Polańska B., Uchmanowicz I., et al. Malnutrition and Quality of Life in Patients with Non-Small-Cell Lung Cancer // Adv Exp Med Biol. 2017. Vol. 1021. P. 15–26. doi: 10.1007/5584_2017_23

[35] Ivanova AS, Obukhova OA, Markovich AA, Titova TA. Prevalence of anxiety and depressive disorders in patients with neuroendocrine neoplasia receiving drug treatment. Problems in oncology. 2023;69(3S):396–397. (In Russ). EDN: WRGHIY

[36] Иванова А.С., Обухова О.А., Маркович А.А., Титова Т.А. Распространенность тревожных и депрессивных расстройств у пациентов с нейроэндокринными неоплазиями, получающими лекарственное лечение // Вопросы онкологии. 2023. Т. 69, № 3S. С. 396–397. EDN: WRGHIY

[37] Kupriyanova IE, Choinzonov ETs, Tuzikov SA, Gural ES. Quality of life and clinical characteristics of patients with cancer of various localizations (lungs, stomach, and intestine). Sibirskii vestnik psikhiatrii i narkologii. 2014;(1(82)):55–59. EDN: RZKSGX

[38] Куприянова И.Е., Чойнзонов Е.Ц., Тузиков С.А., Гураль Е.С. Качество жизни и клинические характеристики пациентов, страдающих раком различной локализации (легких, желудка, кишечника) // Сибирский вестник психиатрии и наркологии. 2014. № 1 (82). С. 55–59. EDN: RZKSGX

[39] Morrison EJ, Novotny PJ, Sloan JA, et al. Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin Lung Cancer. 2017;18(5):497–503. doi: 10.1016/j.cllc.2017.02.008

[40] Morrison E.J., Novotny P.J., Sloan J.A., et al. Emotional problems, quality of life, and symptom burden in patients with lung cancer // Clin Lung Cancer. 2017. Vol. 18, N 5. P. 497–503. doi: 10.1016/j.cllc.2017.02.008

[41] De Haan JJ, Moshage Y, Renken RJ, et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment. Support Care Cancer. 2021;29(10):5691–5699. doi: 10.1007/s00520-021-06049-4

[42] De Haan J.J., Moshage Y., Renken R.J., et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment // Support Care Cancer. 2021. Vol. 29, N 10. P. 5691–5699. doi: 10.1007/s00520-021-06049-4

RIGHTS & PERMISSIONS

Eco-Vector